Dr. Nicolas Garel in the media
- Mar 10
- 2 min read
Updated: Apr 9
Dr. Garel has appeared in the media numerous times since 2024. Find articles and interviews highlighting his contributions to research in addiction psychiatry, mood disorders, psychedelic-assisted therapies, and other innovative therapeutic approaches in the list below.
Radio-Canada
Monday, July 11, 2022
In this article, Dr. Nicolas Garel outlines the conditions under which psychedelic drugs may be used to treat certain mental health disorders, as part of the special access program established by Health Canada.
Genomic Press
June 14th, 2024
In this interview, Dr. Nicolas Garel shares his work on integrating ketamine and serotonergic psychedelics with psychotherapy to treat comorbid mood and substance use disorders. The interview explores his career trajectory, scientific vision, and commitment to developing innovative, evidence-based treatments for patients with treatment-resistant depression and addiction.
La Presse
June 18th, 2025
A La Presse feature highlights a groundbreaking clinical trial showing that the Montreal Model, combining ketamine treatment with a structured therapeutic environment and psychotherapy, provides longer-lasting relief for people with treatment-resistant depression than standard approaches.
EurekAlert!
September 5th, 2022
This interview highlights Dr. Nicolas Garel’s innovative clinical and neurobiological approach to advancing care for patients with complex, treatment-resistant conditions.
La Presse
January 21st, 2024
This article highlights the emergence of innovative treatments that have helped hundreds of Quebecers overcome long-standing, treatment-resistant suicidal ideation after decades of therapeutic stalemate.
Ketamine International Journal Club and Conference
June 27th, 2023
This recorded presentation covers a case series that examines the use of intravenous ketamine in patients with treatment-resistant depression who did not respond to transcranial magnetic stimulation (TMS).
McGill Health e-News
June 30, 2025
A McGill-led clinical trial found that combining ketamine with psychotherapy and supportive treatment settings can extend relief from severe, treatment-resistant depression and reduce anxiety and suicidal thoughts
Radio Canada
October 29, 2024
In this episode, Psychiatrist Nicolas Garel explains the effects of psychedelic drugs on the brain, their therapeutic potential, and the risks associated with them